Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 8, 1999

View Archived Issues

Licensing opportunity from NIH: novel acyltriazene antitumor agents

TxA2 synthase inhibitor may have application in SAH

Bioniche completes merger to create Bioniche Life Sciences

Growth hormone tested in HIV-positive patients with opportunistic infections

Company Profile: Intracel

Selective glucocorticoid receptor modulators codeveloped by Abbott, Ligand

Searle claims wide series of new CETP inhibitors for hyperlipidemic conditions

Novel pyridine and pyrimidine derivatives from Amgen particularly useful for obesity Rx

Antiproliferative agents and protein farnesyltransferase inhibitors designed at RPR

Georgetown U discloses new classes of neuroprotective compounds

Pyrimidine derivatives from Tularik useful for CMV infections

FIP '99: complexes of NO donor with improved physicochemical and pharmacological properties

Sublingual nicotine tablets as alternative to Nicorette gum: clinical results reported at FIP '99

Favorable pharmacokinetics and pharmacodynamics reported for insulin aspart at FIP '99

Valentis and PolyMASC finalize merger

FibroGen and Taisho to collaborate on kidney fibrosis research

Onyx to initiate phase III trial with ONYX-015 in treatment of head and neck cancer

Kirin Brewery reports SAR in the area of Fas/FAP-1 binding inhibitors

D-Pharm's valproic acid derivative completes safety studies

MGI Pharma begins to copromote Azulfidine EN-tabs in RA

Imaging agent NeoTect available in U.S. for lung cancer diagnosis

Novel antibiotics targeting bacterial cell wall biosynthesis synthesized by Incara

Micrologix Biotech receives fast track designation for antimicrobial product

Rhone-Poulenc to proceed with complete divestment of participation in Rhodia

More on Hughes Institute's new anti-HIV compounds with efficacy against resistant strains

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...